Cryptococcus neoformans : a Sugar-Coated Killer

作者: John R Perfect , None

DOI: 10.1128/9781555815776.CH21

关键词:

摘要: The main principles for the genetic pathophysiology of cryptococcosis will probably be consistent among all three varieties. In this chapter author considers yeasts to different varieties or serotypes. Seven major areas are examined support potential molecular insights into pathogenic yeast which allow one identify drug targets, define resistance mechanisms, and/or prepare mutants fungal products protective vaccines. Initial biology studies focused on distinguishing strain differences with use karyotypes, repetitive elements, and eventually randomly amplified polymorphic DNAs, amplification fragment length polymorphisms, PCR fingerprinting genotyping. Cryptococcus neoformans has several well-characterized virulence phenotypes have been approached in their understanding by both tools. Experimental animal models tended associated large inocula some type induced immunosuppression. summary, encapsulated C. developed a human pathogen over last two decades. It causes serious infection we can treat, but it is still substantial morbidity mortality correctly called sugar-coated killer neoformans, keys place unlock mysteries what means pathogen. This basidiomycete become model study pathogenesis, although unique features, many paradigms discovered its used understand other invasive mycoses.

参考文章(189)
J F Hoy, J B Carlin, S M Crowe, K I Stewart, C R Lucas, Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes. ,vol. 4, pp. 770- 776 ,(1991)
Richard J. Hamill, Richard J. Hamill, Samuel A. Shelburne, The immune reconstitution inflammatory syndrome. Aids Reviews. ,vol. 5, pp. 67- 79 ,(2003)
S GILES, J PERFECT, G COX, Cytochrome c peroxidase contributes to the antioxidant defense of Cryptococcus neoformans. Fungal Genetics and Biology. ,vol. 42, pp. 20- 29 ,(2005) , 10.1016/J.FGB.2004.09.003
Frédérique Moyrand, Birgit Klaproth, Uwe Himmelreich, Françoise Dromer, Guilhem Janbon, Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans. Molecular Microbiology. ,vol. 45, pp. 837- 849 ,(2002) , 10.1046/J.1365-2958.2002.03059.X
Hyeseung Lee, Yun C. Chang, K. J. Kwon-Chung, TUP1 disruption reveals biological differences between MATa and MATα strains of Cryptococcus neoformans Molecular Microbiology. ,vol. 55, pp. 1222- 1232 ,(2004) , 10.1111/J.1365-2958.2004.04458.X
Peter R. Kraus, Deborah S. Fox, Gary M. Cox, Joseph Heitman, The Cryptococcus neoformans MAP kinase Mpk1 regulates cell integrity in response to antifungal drugs and loss of calcineurin function Molecular Microbiology. ,vol. 48, pp. 1377- 1387 ,(2003) , 10.1046/J.1365-2958.2003.03508.X
Brunella Posteraro, Maurizio Sanguinetti, Dominique Sanglard, Marilena La Sorda, Stefania Boccia, Lucio Romano, Giulia Morace, Giovanni Fadda, Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole Molecular Microbiology. ,vol. 47, pp. 357- 371 ,(2003) , 10.1046/J.1365-2958.2003.03281.X
Galen B. Toews, Steven L. Kunkel, Robert M. Strieter, Marie D. Burdick, Roderick A. McDonald, Gary B. Huffnagle, Lisa K. McNeil, Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. Journal of Immunology. ,vol. 159, pp. 318- 327 ,(1997)